Momentum builds towards historic Dakar 2026 YOG
20 March 2025 - With the fourth Summer Youth Olympic Games (YOG) now…
Top 10 Change-Makers Driving Sustainable Growth in India Unveiled by Kiteskraft Productions LLP
CHANDIGARH, India, March 20, 2025 /PRNewswire/ -- India's progress is driven by visionary…
Press Release Biocartis NV: Biocartis Announces Multiple Abstracts Demonstrating the Impact of Idylla in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting
PRESS RELEASE 18/03/2025, 07:00 CET Biocartis Announces Multiple Abstracts Demonstrating the Impact…
Vektor Medical Strengthens Leadership Team to Accelerate Commercial Growth and Market Expansion
Corporate Update to be Presented at LSI USA SAN DIEGO--(BUSINESS WIRE)--#HRX2024--Vektor Medical,…
Tour 2025 Presented by Snapdragon: Manchester United to Join Premier League Summer Series
Tour 2025 Presented by Snapdragon, will see Manchester United return to the…
Data of InnoCare’s ICP-488 for the Treatment of Psoriasis Presented at Late Breaking Oral Presentation of 2025 AAD
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing…
Dupixent (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD
Five times more adults on Dupixent achieved sustained disease remission at 36…
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five…
Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis
ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor…
LEO Pharma Presents New Late-Breaking Delgocitinib Cream Data For the Third Consecutive Year at AAD 2025
The post hoc analysis investigated treatment responses in a patient subgroup with…